CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating

Positive
AI Analysis

Summary

Wedbush doubled its price target for First Tracks Biotherapeutics from $30 to $60 while maintaining an Outperform rating on the stock.

Importance:3/10
Sentiment:
0.60
analyst_upgradeprice_target_increaserating_maintained
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 2:20 PM

Read Original